Back to Results

Imv Inc (IMVIF)

IMV Inc is a clinical-stage biotechnology company focused on immuno-oncology. Its research platform is built around DPX, a technology designed to stimulate immune responses for use in cancer therapies. The company’s most advanced candidate is maveropepimut-S, a DPX-based immunotherapy being studied in Phase II trials for diffuse large B-cell lymphoma, ovarian cancer, bladder cancer, liver cancer, and MSI-H solid tumors, and in Phase I testing for breast cancer. IMV also is developing DPX-SurMAGE for bladder cancer, along with DPX-COVID-19 and DPX-RSV for infectious diseases. The company was established in 2000, changed its name from Immunovaccine Inc. in 2018, and is headquartered in Dartmouth, Canada.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Analyst Price Target	Analyst Target Upside/Downside	Overall Financial Health	Dividend Yield	Market Cap
OTC-IMVI.F	Not available	Not available	Not available	Weak	0.0%	0.014 K

Smart Snapshot

Stock Overview

A fast read of the company and market metrics currently supported by the latest data.

Company Profile

Sector

Healthcare

Industry

Biotechnology

Quality & Risk

Financial Health

Weak

Valuation • Fair Value

Imv Inc (OTC-IMVI.F) Fair Value by Valuation Model

No usable valuation estimate is currently available for Imv Inc (OTC-IMVI.F); fair value and analyst target coverage statuses are shown explicitly below.

Primary Valuation Read

Fair Value

Not available

Data is currently unavailable.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

No usable valuation estimate is currently available for Imv Inc (OTC-IMVI.F). Fair value and the analyst target remain visible as coverage-status fields and should not be read as valuation signals while unavailable.

Profitability • Growth

Profitability & Growth for Imv Inc (OTC-IMVI.F)

Review the profitability and growth indicators currently supported by the latest data.

EBITDA

0 K

Current operating profitability reference.

How to read profitability and growth

This section helps investors review Imv Inc (OTC-IMVI.F) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Imv Inc (OTC-IMVI.F)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Weak

Financial pressure deserves closer review.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Imv Inc (OTC-IMVI.F). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Dividend Profile for Imv Inc (OTC-IMVI.F)

Review the dividend metrics currently supported by the latest data.

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

The latest data indicates no current dividend yield for Imv Inc (OTC-IMVI.F). No upcoming dividend amount or event date is currently available.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy

Time frame: daily • daily

Strong Sell

The daily technical read for Imv Inc (OTC-IMVI.F) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy

Time frame: weekly • weekly

Strong Sell

The weekly technical read for Imv Inc (OTC-IMVI.F) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy

Time frame: monthly • monthly

Strong Sell

The monthly technical read for Imv Inc (OTC-IMVI.F) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ • Fast Investor Answers

Imv Inc (OTC-IMVI.F) Stock FAQ

Data-supported answers about Imv Inc (OTC-IMVI.F), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value

Not available

No reliable estimate from the currently supported inputs

Financial Health

Weak

Current financial-health read

A reliable fair value estimate is not currently available for Imv Inc (OTC-IMVI.F). This generally means the latest dataset does not contain enough valid inputs for the valuation models supported by PriceToWorth. The site does not substitute zero or publish an unsupported estimate; availability may change when updated financial data or applicable model inputs become available.

The current financial health read for Imv Inc (OTC-IMVI.F) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The latest available data indicates no current dividend yield for Imv Inc (OTC-IMVI.F).

The current market capitalization listed for Imv Inc is 0.014 K.

The ticker symbol for Imv Inc is OTC-IMVI.F, and the stock is listed on OTC Markets.

Imv Inc (OTC-IMVI.F) is listed on OTC Markets.